Global private equity giant KKR has agreed to buy a 54% stake in Indian pharmaceutical business JB Chemicals, in a deal which could ultimately see it commit $500m to the company.
Buyout
deal
drug
emerging market
India
invest
investment
JB Chemicals
KKR
medicine
pharma
Pharma and Healthcare
private equity
Software and Hi-Tech
therapy
treatment
KKR buys into Indian pharma company JB Chemicals, deal could reach $500m
Most Popular
